StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

NeoGenomics's EV/EBITDA was 783.4× on Jul 31, 2020, against 240.0× a year earlier. Over the last 5 years it ranged from 31.6× to 783.4×, with a median of 184.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2020Jul 31, 2020783.4×+563.0
2019Dec 31, 2019220.4×+113.8
2018Dec 31, 2018106.6×−212.1
2017Apr 28, 2017318.7×−280.6
2016Apr 29, 2016599.3×+538.5
2015Dec 31, 201560.9×−44.2
2014Dec 31, 2014105.1×+25.5
2013Dec 31, 201379.6×+0.3
2012Dec 31, 201279.2×–

More NeoGenomics figures

See a number that looks wrong?